Clincosm LogoSign in Get a demo

Transplantation of Autologous Oral Mucosal Epithelial Stem Cell Sheet for Treating Limbal Stem Cell Deficiency Disease

Sponsor
He Eye Hospital (Other)
Overall Status
Unknown status
CT.gov ID
NCT03015779
Collaborator
(none)
7
Enrollment
1
Arm
23
Duration (Months)

Study Details

Study Description

Brief Summary

The aim of this trials investigates the therapeutic effects of application autologous oral mucosal epithelial cell sheets in the treatment of limbal stem cell deficiency disease.

Condition or Disease Intervention/Treatment Phase
  • Other: cultured autologous oral mucosal epithelial cell sheet
 Phase 1/Phase 2

Detailed Description

A number of external factors can result in limbal stem cell deficiency(LSCD), causing pain, pathological corneal epithelium regeneration, inflammation reaction and seriously visual loss. For patients with unilaterally damaged eye, transplantation of limbal tissue from the healthy eye can be used in the past years in the risk of inducing limbal stem cell damaged in the healthy eye. While graft of human leukocyte antigen matched allogenic limbal stem cells require immune suppressive medications, it can cause side effects in the body. Over the past 10 years, the clinical trials of application of cultured autologous oral mucosal epithelial cell sheet to treat LSCD have been emerged as a promising strategy in many countries. However, little study has been reported in China. This study investigates the therapeutic effects of application autologous oral mucosal epithelial cell sheets in the treatment of limbal stem cell deficiency disease in China.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
7 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Transplantation of Autologous Oral Mucosal Epithelial Stem Cell Sheet for Treating Limbal Stem Cell Deficiency Disease
Study Start Date :
Jan 1, 2017
Anticipated Primary Completion Date :
Dec 1, 2017
Anticipated Study Completion Date :
Dec 1, 2018

Arms and Interventions

Arm Intervention/Treatment
Experimental: experimental group

cultured autologous oral mucosal epithelial cell sheet

Other: cultured autologous oral mucosal epithelial cell sheet
a prospective study,Before and after self control

Outcome Measures

Primary Outcome Measures

  1. The area of reepithelialization of corneal epithelium [3 months]

    The preoperative status of the eye will be recorded on the basis of clinical drawings and pre-and post-operative photographs. These pictures will be sent to two corneal experts in order to evaluate the results. Judgement criterion: the results will be tested with a slit lamp: Normal: no epithelial loss; Mild: the area of epithelial loss <1/3; Moderate: the area of epithelial loss >1/3 <2/3; Severe: the area of epithelial loss> 2/3

Secondary Outcome Measures

  1. Improvement of best correct visual acuity [one year]

  2. Decrease of corneal neovascularization [one year]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:

  • Male or female aged>=18 years old

  • Normal intraocular pressure

  • Normal Eyelid

  • No cataract and retinal disease

  • No ulcers and tumor in the mouth

Exclusion Criteria:

  • Severe Systemic infection

  • History of acute phase of ocular and oral inflammation

  • History of hyper sensibility or allergy to antibiotics or serum

  • Women who are or may be pregnant

  • Patients with infectious diseases

  • Patients with other complications

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • He Eye Hospital

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
He Eye Hospital
ClinicalTrials.gov Identifier:
NCT03015779
Other Study ID Numbers:
  • 20161029
First Posted:
Jan 10, 2017
Last Update Posted:
Jan 10, 2017
Last Verified:
Jan 1, 2017
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Additional relevant MeSH terms:
Deficiency Diseases

Study Results

No Results Posted as of Jan 10, 2017